Log in to save to my catalogue

Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy...

Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4753416

Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer

About this item

Full title

Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2016-02, Vol.6 (1), p.21225, Article 21225

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Ample attention has focused on cancer drug delivery via prodrug nanoparticles due to their high drug loading property and comparatively lower side effects. In this study, we designed a PEG-DOX-Cur prodrug nanoparticle for simultaneous delivery of doxorubicin (DOX) and curcumin (Cur) as a combination therapy to treat cancer. DOX was conjugated to PE...

Alternative Titles

Full title

Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4753416

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4753416

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/srep21225

How to access this item